India Biobanking Market Research Report By Sample Type (Blood Products, Tissues, Cells, Nucleic Acids, Microbiome Samples), By Application (Research and Development, Clinical Trials, Personalized Medicine, Regenerative Medicine), By End Use (Academic Research Institutions, Biotechnology Companies, Pharmaceutical Companies, Government Organizations) and By Storage Type (Vapor Phase Storage, Liquid Phase Storage, Cryopreservation Storage)- Forecast to 2035

India Biobanking Market Overview

As per MRFR analysis, the India Biobanking Market Size was estimated at 197.2 (USD Million) in 2023. The India Biobanking Market Industry is expected to grow from 205.6(USD Million) in 2024 to 361.2 (USD Million) by 2035. The India Biobanking Market CAGR (growth rate) is expected to be around 5.256% during the forecast period (2025 - 2035).

Key India Biobanking Market Trends Highlighted

There are a number of important trends in the India Biobanking Market that show how it is changing. One big reason is that individualized medicine is becoming more important, which means that a lot of biobanking needs to be done to keep and study biological samples. As chronic diseases become more common in India, the need for biobanks that can help with genomes and biomarkers research and development is expanding. 

The National Biopharma Mission and other government programs also aim to improve biotechnological research, which will help the biobanking industry grow even more in the country. There are many chances in the Indian biobanking field, especially now that digital technology are making it easier to keep track of samples and handle data. There are new partnerships between universities and private companies who are trying to set up well-equipped biobanks that can meet the needs of certain types of research. As more and more clinical trials take place in India, there is a lot of room for biorepositories that can supply the biological samples these investigations need. 

Recently, there has been a big change in the India Biobanking Market toward creating standardized biobanking procedures and ethical guidelines. This is because more people are becoming aware of how important it is to keep samples safe and get consent from participants. Also, the growth of biobanks that focus on different groups of people is becoming more important for studying the genetic variety in India's population.This is in line with global trends that show the necessity for representative biobanks to make sure that research results apply to a wide range of people, which would improve the overall quality of biomedical research in India.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

India Biobanking Market Drivers

Growing Prevalence of Genetic Disorders and Chronic Diseases in India

The increasing rate of genetic disorders and chronic diseases such as diabetes, cancer, and cardiovascular ailments is significantly driving the India Biobanking Market Industry. According to data from the Indian Council of Medical Research, approximately 10 million new cases of cancer are reported in India annually, representing an alarming rise in the demand for biobanking. 

Organizations like the Tata Memorial Centre are working on various genomics projects aimed at understanding cancer better through biobanks, highlighting the urgent need for biological samples to facilitate research and treatment developments.Additionally, the National Health Mission has noted that diabetes is projected to affect over 134 million individuals in India by 2025, necessitating the collection and storage of biological samples for research purposes. This growing prevalence emphasizes the critical role of biobanks in advancing medical therapies, translating to a significant market potential.

Increasing Investment in Research and Development for Precision Medicine

The rise of precision medicine is a key driver of the India Biobanking Market Industry, fueled by increased investment in Research and Development (R&D) initiatives. The Department of Biotechnology under the Ministry of Science and Technology has launched various programs encouraging the establishment of biobanks to collect and analyze biological samples, particularly for targeted therapies. 

Institutions such as the All India Institute of Medical Sciences (AIIMS) are increasingly adopting biobanking practices to enhance their research capabilities.With an estimated increase in funding for translational research to reach up to 10 billion USD by 2025, the demand for biobanks as critical resources for precision medicine is expected to see substantial growth.

Rising Public Awareness and Support for Biobanking Initiatives

Public awareness surrounding health issues and the significance of biobanking is growing, which is aiding the India Biobanking Market Industry. Initiatives led by non-profit organizations and government health agencies to educate the public about the benefits of biobanking are proving effective. 

According to a survey conducted by the Ministry of Health and Family Welfare, 78% of Indians believe that biobanks can contribute to better health outcomes through research.The Indian Biobank Association plays a pivotal role in raising awareness about biological resource collections and their importance in enhancing research methodologies, driving public and private investments into biobanking.

India Biobanking Market Segment Insights

Biobanking Market Sample Type Insights

The India Biobanking Market, especially the Sample Type sector, has a lot of different parts that are important for different scientific uses. As biobanking grows more popular in India, especially for research, clinical trials, and customized treatment, the importance of sample types such blood products, tissues, cells, nucleic acids, and microbiome samples becomes clearer. Blood products are very important since they are the basis for many research and development projects that focus on haematological studies and diagnostics. Tissues are also very important for researchers because they let them learn about how diseases work and test novel drugs. 

Cells, including stem cells and immune cells, are very important for regenerative medicine and therapeutic innovations since they provide a lot of information for clinical use. DNA and RNA are examples of nucleic acids that are important for genomics and proteomics research. These studies help make progress in personalized healthcare and precision medicine. Lastly, Microbiome Samples are getting a lot of attention right now because they can help us learn more about human health and disease, especially when it comes to metabolic disorders and gastrointestinal health.In general, these different sorts of samples in the India Biobanking Market segmentation not only help with important scientific research, but they also show that there is room for new ideas in many fields, like as healthcare, pharmaceuticals, and biotechnology. 

As customized medicine and tailored therapies become more popular, the demand for these samples is likely to expand a lot. This shows how strong the biobanking ecosystem is in India. The government and private sectors are working together to improve the biobanking infrastructure and encourage collaboration between institutions. This shows that there are more opportunities and growth drivers in the market, making India an emerging hub for biobanking solutions in the global context.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Biobanking Market Application Insights

The Application segment of the India Biobanking Market plays a crucial role in advancing medical research and innovation in the country. With a growing emphasis on Research and Development, the sector is expected to significantly contribute to scientific advancements and therapeutic discoveries. Clinical Trials within this segment are vital, as they enable the testing of new drugs and therapies, thus fostering a more robust healthcare system. Personalized Medicine is gaining traction in India, driven by a shift towards tailored treatments based on individual genetic profiles, enhancing treatment efficacy while reducing adverse effects.

Regenerative Medicine is also pivotal, focusing on regenerating damaged tissues and organs, which aligns with India’s increasing efforts to bolster healthcare services and improve patient outcomes. The overall market is witnessing substantial growth due to increasing investments in biomedical research, enhancement in technological infrastructure, and collaborative efforts between public and private sectors. These factors contribute to an optimistic outlook for the India Biobanking Market, ensuring its critical role in the healthcare ecosystem through innovative applications.

Biobanking Market End Use Insights

The India Biobanking Market has a diverse End Use segmentation, prominently featuring Academic Research Institutions, Biotechnology Companies, Pharmaceutical Companies, and Government Organizations. Academic Research Institutions play a crucial role in advancing scientific studies by enabling access to biological samples for various research purposes, which enhances the region's educational and research capacities. Biotechnology Companies leverage biobanks for the development and innovation of therapeutic solutions, thereby significantly contributing to the sector's growth.

Pharmaceutical Companies rely on biobanks for crucial Research and Development processes, including drug discovery and validation, which fosters advancements in healthcare and enhances patient care. Furthermore, Government Organizations support biobanking initiatives as they align with public health policies and help in disease prevention strategies. This collaboration among diverse players creates an ecosystem that drives innovation and supports the overall growth of the India Biobanking Market, which is poised for robust development due to increasing healthcare demands and advancements in biotechnological research.As a result, the sector witnesses growing interest and investment, laying a strong foundation for further advancements and opportunities within this industry in India.

Biobanking Market Storage Type Insights

The Storage Type segment of the India Biobanking Market plays a crucial role in maintaining the integrity of biological samples for Research and Development purposes and other applications. Vapor Phase Storage is significant due to its ability to maintain low temperatures, ensuring the long-term preservation of sensitive biological materials without the risk of contamination. In contrast, Liquid Phase Storage offers advantages in accessibility and sample retrieval, appealing to laboratories requiring frequent access to samples. 

Furthermore, Cryopreservation Storage has gained prominence because of its effectiveness in preserving cells, tissues, and other biological specimens through ultra-low temperatures.This technique not only extends the viability of these samples but also has become a preferred choice for various biobanking organizations. As the focus on personalized medicine and advanced therapies grows, the demand for efficient storage solutions across these methods is expected to rise, driven by the need for high-quality biobanked samples. The expanding India Biobanking Market segmentation reflects these dynamics, identifying the importance of optimal storage techniques in supporting scientific advancements and healthcare innovation.

India Biobanking Market Key Players and Competitive Insights

The India Biobanking Market has grown and changed a lot because of improvements in biotechnology, healthcare research, and the growing need for tailored medication. Competitive insights show that this market has a wide range of biobanks that meet different research goals and commercial needs while also taking into account ethical issues related to collecting and storing samples. There are both private and public companies in the market, and they all want to be the best by using new technology, forming strategic relationships, and building strong infrastructure. Biobanking is heavily dependent on research institutions and hospitals, which help researchers work together to get more and different biological samples. 

This makes it easier for researchers to study genetics and diseases. As new companies enter the market and existing ones add more services, the competitive landscape keeps changing. This is because biobanks are becoming more important in the healthcare ecosystem. Apollo Hospitals is a major player in the India Biobanking Market because of its large network and good reputation for providing great healthcare. The organization uses its current infrastructure to provide full biobanking solutions that fit with its dedication to cutting-edge research and patient care. Its strengths come from its established healthcare delivery platforms, which make it easy to collect and handle biological samples quickly. Apollo Hospitals uses biobanking in its clinical operations to help with cutting-edge research projects that attempt to improve patient outcomes. This is part of their focus on customized treatment. The firm benefits from its brand recognition and trust, which allows it to make strategic agreements and work with top academic institutions and research groups. This gives it an even stronger competitive edge in the biobanking field.

Neuberg diagnoses is another important company in the India Biobanking Market. It is known for its wide range of laboratory services and dedication to improving diagnoses. The business provides a wide range of biobanking services, such as collecting, storing, and analysing samples for both research and clinical purposes. Neuberg Diagnostics has a significant presence in the market thanks to its cutting-edge technology and state-of-the-art labs, which make biobanking procedures of the highest quality possible. It is a popular choice for research collaborations since it places a strong emphasis on quality assurance and following international standards. 

The organization has formed a number of strategic agreements and partnerships to improve its biobanking capabilities, which guarantees a consistent supply of biological samples for different projects. Neuberg Diagnostics is also working to grow its presence in the biobanking field. This shows that the company is dedicated to improving healthcare research in India by offering new services and complete biobanking solutions.

Key Companies in the India Biobanking Market Include:

• Apollo Hospitals


• Neuberg Diagnostics


• Cryobank


• Predicine India


• GSK India


• Tata Medical Center


• Bharat Serums and Vaccines


• MediFutures


• SRL Diagnostic


• Dr. Lal PathLabs


• Fortis Healthcare


• Panacea Biotec


• Biocon


• StemCyte India


• Lifecell International

India Biobanking Market Industry Developments

Recent developments in the India Biobanking Market have been significant, with major players focusing on enhancing their infrastructure and technological capabilities. Apollo Hospitals has announced strategic initiatives to expand its biobanking services, aligning with the growing demand for personalized medicine. Neuberg Diagnostics has been actively investing in state-of-the-art biobanking facilities to support its research endeavors. 

In terms of mergers and acquisitions, there have been noteworthy partnerships, such as Cryobank's acquisition of Lifecell International, reported in July 2023, aimed at strengthening their market presence. GSK India has also partnered with various institutions to facilitate the advancement of biobank research, promoting extensive collaboration within the scientific community. 

The market valuation of companies like Bharat Serums and Vaccines and Tata Medical Center has seen an upward trend, reflecting a strong commitment to biobanking, which is expected to drive innovation and improve patient outcomes. Significant events from the past couple of years include the regulation changes by the Indian Council of Medical Research in June 2022, which have encouraged biobanking practices, leading to the enhancement of operational standards and ethical guidelines in the sector.

India Biobanking Market Segmentation Insights

Biobanking Market Sample Type Outlook

• Blood Products


• Tissues


• Cells


• Nucleic Acids


• Microbiome Samples

Biobanking Market Application Outlook

• Research and Development


• Clinical Trials


• Personalized Medicine


• Regenerative Medicine

Biobanking Market End Use Outlook

• Academic Research Institutions


• Biotechnology Companies


• Pharmaceutical Companies


• Government Organizations

Biobanking Market Storage Type Outlook

• 
  

  Vapor Phase Storage

  
  


• 
  

  Liquid Phase Storage

  
  


• 
  

  Cryopreservation Storage

  
  

Report Attribute/Metric Source:	Details
MARKET SIZE 2023	197.2(USD Million)
MARKET SIZE 2024	205.6(USD Million)
MARKET SIZE 2035	361.2(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR)	5.256% (2025 - 2035)
REPORT COVERAGE	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR	2024
MARKET FORECAST PERIOD	2025 - 2035
HISTORICAL DATA	2019 - 2024
MARKET FORECAST UNITS	USD Million
KEY COMPANIES PROFILED	Apollo Hospitals, Neuberg Diagnostics, Cryobank, Predicine India, GSK India, Tata Medical Center, Bharat Serums and Vaccines, MediFutures, SRL Diagnostic, Dr. Lal PathLabs, Fortis Healthcare, Panacea Biotec, Biocon, StemCyte India, Lifecell International
SEGMENTS COVERED	Sample Type, Application, End Use, Storage Type
KEY MARKET OPPORTUNITIES	Increased demand for personalized medicine, Rising prevalence of chronic diseases, Expanding genomics and proteomics research, Government support and funding initiatives, Collaboration with pharmaceutical companies
KEY MARKET DYNAMICS	Increasing healthcare investments, Rising population awareness, Advanced research initiatives, Regulatory support enhancement, Growth in personalized medicine
COUNTRIES COVERED	India